首页> 外文期刊>Annals of hematology >Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
【24h】

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

机译:骨髓增生异常少于5%的骨髓增生异常综合征的观察者间差异:单谱系vs.多谱系发育异常和2%胚泡阈值的可重复性

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies have shown the reproducibility of the 2008 World Health Organization (WHO) classification in myelodysplastic syndromes (MDS), especially when multilineage dysplasia or excess of blasts are present. However, there are few data regarding the reproducibility of MDS with unilineage dysplasia. The revised International Prognostic Scoring System R-IPSS described two new morphological categories, distinguishing bone marrow (BM) blast cell count between 0-2 % and > 2-aEuro parts per thousand < 5 %. This distinction is critical for establishing prognosis, but the reproducibility of this threshold is still not demonstrated. The objectives of our study were to explore the reliability of the 2008 WHO classification, regarding unilineage vs. multilineage dysplasia, by reviewing 110 cases previously diagnosed with MDS, and to study whether the threshold of a parts per thousand currency sign2 % BM blasts is reproducible among different observers. We used the same methodology as in our previous paper [Font et al. (2013) Ann Hematol 92:19-24], by encouraging investigators to include patients with < 5 % BM blasts. Samples were collected from 11 hospitals and were evaluated by 11 morphologists. Each observer evaluated 20 samples, and each sample was analyzed independently by two morphologists. Discordance was observed in 36/108 suitable cases (33 %, kappa test 0.503). Diagnosis of MDS with unilineage dysplasia (refractory cytopenia with unilineage dysplasia (RCUD), refractory anemia with ring sideroblasts (RARS) or unclassifiable MDS) was assessed in 33 patients, by either of the two observers. We combined this series with the cases with RCUD or RARS included in our 2013 paper, thus obtaining 50 cases with unilineage dysplasia by at least one of the observers. The whole series showed very low agreement regarding RCUD (5/23, 21 %) and RARS (5/28, 18 %). Regarding BM blast count, the threshold of a parts per thousand currency sign2 % was not reproducible (discordance rate 32/108 cases, kappa test 0.277). Our study shows that among MDS WHO 2008 categories, interobserver discordance seems to be high in cases with unilineage dysplasia. We also illustrate that the threshold of a parts per thousand currency sign2 % BM blasts as settled by the R-IPSS may be not easy to reproduce by morphologists in real practice.
机译:先前的研究表明,2008年世界卫生组织(WHO)分类在骨髓增生异常综合症(MDS)中具有可重复性,尤其是在存在多谱系发育异常或胚泡过多的情况下。但是,关于单边发育异常的MDS的可重复性的数据很少。修订后的国际预后评分系统R-IPSS描述了两个新的形态学类别,将骨髓(BM)胚细胞的数量区分为0-2%至> 2-aEuro千分之一<5%。这种区别对于确定预后至关重要,但仍未证明该阈值的可重复性。我们研究的目的是通过审查110例先前诊断为MDS的病例,探讨2008年WHO分类法关于单谱系与多谱系发育异常的可靠性,并研究是否可重现每千个货币符号中2%BM爆炸的阈值在不同的观察者之间。我们使用了与先前论文相同的方法[Font等。 (2013)Ann Hematol 92:19-24],鼓励研究者纳入BM blast <5%的患者。从11家医院收集样本,并由11位形态学家进行评估。每个观察者评估了20个样品,每个样品由两名形态学家独立分析。在36/108个合适的案例中观察到不一致(33%,kappa测试为0.503)。由两名观察者中的任一个评估了33例患者的单眼发育异常(难治性血细胞减少症伴单眼发育异常(RCUD),难治性贫血伴环状铁粒母细胞(RARS)或无法分类的MDS)的MDS诊断。我们将该系列与2013年论文中包含RCUD或RARS的病例相结合,从而由至少一位观察者获得了50例单眼发育异常的病例。整个系列在RCUD(5/23,21%)和RARS(5/28,18%)上的一致性很低。关于BM爆炸计数,千分率2%的阈值不可重现(不一致率32/108例,kappa测试为0.277)。我们的研究表明,在2008年MDS WHO类别中,单子系发育不良的病例之间观察者间的不一致性似乎很高。我们还说明,由R-IPSS确定的千分之一货币符号2%BM爆炸阈值在实际实践中可能不容易被形态学家再现。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号